Nitric Acid

Nitric Acid

SCHEMBL6530372

CC(C)c1ccc2[nH]ncc2c1Br.O=[N+]([O-])O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ERG11

The experimentally established mechanism targets of Nitric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NOS1 P29475 4/20 0.42
▸ AXL P30530 1/20 0.41
▸ MAPT P10636 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ MAOB P27338 1/20 0.36
▸ P4HB P07237 1/20 0.35
▸ TRPA1 O75762 1/20 0.35
▸ IDO1 P14902 7/20 0.34
▸ TDO2 P48775 5/20 0.34
▸ LMNA P02545 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ CCNA2 P20248 1/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ CCNA1 P78396 1/20 0.33
▸ TRPV1 Q8NER1 3/20 0.33
▸ METAP2 P50579 1/20 0.33
▸ PDK1 Q15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21271929 0.73 NOS1 (0.61) NOS1AXLMAPTPOLBMAOB
SCHEMBL22281317 0.71 TRPA1 (0.42) NOS1AXLTRPA1IDO1CDK2
SCHEMBL16746127 0.71 TRPA1 (0.42) NOS1AXLTRPA1IDO1CDK2
SCHEMBL20618762 0.69 TRPA1 (0.44) NOS1AXLP4HBTRPA1IDO1
SCHEMBL14803988 0.69 NOS1 (0.46) NOS1AXLTRPA1IDO1CDK2
SCHEMBL61091 0.69 TRPA1 (0.38) NOS1AXLTRPA1IDO1CCNA2
SCHEMBL10282903 0.69 TRPA1 (0.38) NOS1AXLMAPTTRPA1IDO1
SCHEMBL21341312 0.68 TRPA1 (0.40) NOS1AXLTRPA1IDO1CCNA2
SCHEMBL24944422 0.67 BRD4 (0.44) NOS1AXLTRPA1IDO1CDK2
SCHEMBL1965090 0.67 NOS1 (0.53) NOS1AXLMAPTPOLBMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1565452-A2 3-SUBSTITUTED-6-ARYL PYRIDINES AS LIGANDS OF C5A RECEPTORS NEUROGEN CORPORATION (US) 2005-08-24 — — EP disclosed
WO-2004043925-A2 3-SUBSTITUTED-6-ARYL PYRIDINED AS LIGANDS OF C5A RECEPTORS NEUROGEN CORPORATION (US) 2004-05-27 — — WO disclosed
Send feedback